ester
lipophil
antioxid
antivir
b
r
c
water
solubl
green
tea
polyphenol
epigallocatechin
gallat
egcg
lipophilis
esterif
differ
fatti
acid
expand
applic
four
lipophil
ester
deriv
egcg
name
egcgotetrastear
egcgotetraeicosapentaeno
egcgotetradocosahexaeno
egcgooctabutyr
prepar
evalu
antioxid
antivir
activ
vitro
incorpor
fatti
acid
especi
long
chain
polyunsatur
fatti
acid
pufa
egcg
result
increas
peroxyl
radic
scaveng
activ
measur
orac
oxygen
radic
absorb
capac
assay
metal
chelat
capac
howev
ester
exhibit
decreas
reduc
power
antivir
activ
egcg
deriv
remark
higher
parent
egcg
molecul
show
rel
weak
effect
egcgpufa
ester
effect
inhibit
hepat
c
viru
hcv
proteas
posit
control
embelin
deriv
also
act
aglucosidas
inhibitor
suggest
potenti
antihiv
human
immunodefici
viru
treatment
result
suggest
ester
deriv
egcg
improv
bioactiv
may
serv
excel
function
food
ingredi
natur
health
product
moreov
pufa
deriv
may
also
render
addit
synergist
health
benefit
tea
tea
product
contain
substanti
amount
bioactiv
flavonoid
proven
render
multipl
function
physiolog
effect
cabrera
artacho
nez
mani
health
effect
relat
tea
consumpt
attribut
catechin
simpl
condens
content
also
respons
characterist
colour
flavour
aroma
tea
among
catechin
found
tea
epigallocatechin
gallat
egcg
predomin
one
mckay
blumberg
extens
studi
potenti
health
promot
agent
egcg
four
ring
structur
hydroxyl
group
readili
dissolv
water
sparingli
solubl
hydrophob
media
hydrophil
natur
egcg
restrict
bioeffici
lipophil
environ
due
limit
solubl
henc
hinder
approach
site
action
moreov
hydrophil
egcg
may
account
poor
cellular
absorpt
vivo
thu
low
bioavail
ingest
oral
order
take
better
advantag
multifunct
compound
watersolubl
egcg
structur
modifi
esterif
differ
fatti
acid
includ
stearic
sa
eicosapentaeno
epa
docosahexaeno
dha
acid
describ
elsewher
zhong
shahidi
tetraest
produc
show
enhanc
lipophil
improv
radic
scaveng
capac
compar
egcg
lipophilis
egcg
esterif
may
use
improv
bioeffici
lipophil
media
even
introduc
novel
bioactiv
due
fatti
acid
moieti
incorpor
especi
health
benefici
longchain
polyunsatur
fatti
acid
pufa
involv
studi
design
investig
lipophilis
egcg
deriv
potenti
altern
egcg
incorpor
food
natur
health
product
four
egcgfatti
acid
ester
fig
name
otetrastear
compound
otetraeicosapentaeno
compound
otetradocosahexaeno
compound
egcgoctabutyr
compound
evalu
antioxid
antivir
activ
vitro
egcg
known
power
antioxid
protect
free
radicalmedi
oxid
chang
food
live
organ
egcg
act
scaveng
mani
reactiv
oxygennitrogen
speci
rosrn
superoxid
radic
anion
peroxyl
hydroxyl
radic
singlet
oxygen
nitric
oxid
peroxynitrit
among
other
reactiv
speci
implic
human
pathogenesi
includ
inflamm
carcinogenesi
egcg
may
trap
peroxyl
radic
thu
break
chain
reaction
free
radic
termin
lipid
oxid
electron
paramagnet
reson
epr
studi
tea
catechin
indic
egcg
trap
superoxid
anion
hydroxyl
radic
wherea
epicatechin
ec
trap
free
radic
yang
sheng
hou
zhao
xin
egcg
also
inhibit
oxid
chelat
metal
ion
iron
copper
catalyst
free
radic
gener
antioxid
activ
egcg
depend
mani
factor
includ
reduc
potenti
chelat
behaviour
ph
solubl
characterist
bioavail
stabil
environ
luczaj
skrzydlewska
turn
determin
structur
featur
molecul
thu
effect
structur
modif
antioxid
activ
egcg
investig
work
antivir
activ
egcg
also
report
egcg
shown
inhibit
matur
replic
infect
function
numer
virus
includ
adenoviru
coronaviru
influenza
viru
rotaviru
herp
simplex
viru
hsv
enteroviru
ev
eg
coxsackieviru
polioviru
hepat
viru
human
immunodefici
viru
hiv
clark
et
al
friedman
ho
cheng
weng
leu
chiu
nanc
siwak
shearer
weber
ruzindanaumunyana
imbeault
sircar
among
other
via
multipl
mechan
antivir
activ
egcg
thought
attribut
abil
act
antioxid
inhibit
enzym
suppress
viral
rna
synthesi
disrupt
cell
membran
bind
virul
protein
thu
prevent
penetr
receptor
cell
trigger
host
cell
selfdefens
mechan
friedman
studi
antivir
potenti
egcg
lipophil
deriv
evalu
vitro
inhibitori
activ
proteas
import
enzym
matur
hepat
c
viru
hcv
aglucosidas
enzym
essenti
hiv
infect
materi
method
egcg
ester
prepar
acyl
egcg
differ
fatti
acid
name
sa
epa
dha
correspond
acyl
chlorid
describ
elsewher
zhong
shahidi
perbutyr
egcg
prepar
use
excess
butyroyl
chlorid
composit
crude
product
contain
mixtur
egcg
polyest
determin
hplcm
predomin
egcg
ester
isol
flash
column
chromatographi
purifi
egcg
ester
purifi
form
compound
identifi
hplcm
h
nmr
c
nmr
subject
antioxid
antivir
activ
assess
use
vitro
assay
orac
assay
egcg
deriv
compound
carri
use
fluostar
optima
plate
reader
bmg
labtech
durham
nc
usa
equip
incub
two
injector
pump
modifi
method
lipophil
antioxid
follow
rmcd
use
water
solubl
enhanc
describ
huang
ou
hampschwoodil
flanagan
deemer
trolox
standard
fig
chemic
structur
egcg
deriv
lm
sampl
lm
dissolv
aceton
water
vv
contain
wv
rmcd
fluorescein
aaph
azobi
dihydrochlorid
use
probe
radic
gener
respect
trolox
standard
test
compound
solut
rmcd
use
control
ad
well
black
micropl
corn
life
scienc
kennebunk
main
usa
follow
fluorescein
phosphat
buffer
solut
lm
plate
incub
min
machin
program
inject
aaph
mgml
buffer
well
condit
use
follow
posit
delay
orbit
shake
cycl
mm
width
cycl
time
cycl
fluoresc
measur
excit
wavelength
nm
emiss
nm
standard
curv
plot
orac
valu
test
compound
obtain
trolox
equival
te
reduc
power
reduc
power
egcg
deriv
compound
determin
accord
oyaizu
one
millilitr
test
compound
mm
ethanol
mix
ml
phosphat
buffer
solut
pb
ph
ml
solut
potassium
ferricyanid
k
fe
cn
mixtur
incub
min
trichloroacet
acid
tca
ml
ad
mixtur
content
centrifug
g
min
aliquot
ml
supernat
transfer
tube
contain
ml
distil
water
ml
ferric
chlorid
fecl
content
mix
well
absorb
record
nm
ascorb
acid
mm
ethanol
use
standard
metal
chelat
capac
egcg
deriv
compound
measur
accord
decker
welch
modif
ethanol
solut
test
compound
ml
mm
mix
well
ml
ethanol
ml
ferrou
chlorid
fecl
mm
mixtur
ml
ferrozin
mm
ad
reaction
mixtur
allow
stand
min
colour
develop
absorb
read
nm
blank
without
ferrozin
use
compound
sinc
antioxidantf
complex
give
colour
might
interfer
absorb
read
metal
chelat
capac
calcul
use
follow
equat
control
devoid
test
compound
blank
contain
ferrozin
inhibitori
activ
egcg
deriv
compound
hcv
proteas
evalu
indic
antivir
activ
assay
conduct
follow
method
describ
wei
wang
hattori
use
sensolyt
hcv
proteas
assay
kit
aliquot
test
compound
dissolv
dimethyl
sulphoxid
dmso
ad
well
black
assay
plate
follow
addit
hcv
proteas
solut
lgml
reaction
initi
ad
freshli
dilut
substrat
dilut
dmso
stock
solut
mixtur
incub
room
temperatur
min
fluoresc
intens
measur
nm
excit
nm
emiss
tecan
genio
plate
reader
inhibitori
activ
test
compound
calcul
inhibit
percentag
accord
follow
equat
f
control
f
sampl
repres
fluoresc
valu
control
without
test
compound
ad
test
compound
fluoresc
valu
correct
substrat
blank
sampl
assay
differ
concentr
plot
concentr
versu
inhibit
percentag
curv
ic
valu
obtain
curv
sampl
known
hcv
proteas
inhibitor
embelin
use
refer
aglucosidas
inhibitori
activ
egcg
deriv
compound
determin
follow
procedur
describ
hattori
daneshtalab
wang
well
plate
adglucopyranosid
mm
dissolv
mm
potassium
phosphat
buffer
ph
sampl
solut
dmso
ad
reaction
initi
ad
enzym
solut
luml
aglucosidas
b
stearothermophilu
plate
incub
min
absorb
read
incub
nm
interm
immunoread
nippon
interm
kk
tokyo
japan
absorb
chang
da
record
compar
control
sampl
inhibitori
activ
test
compound
aglucosidas
calcul
follow
da
control
da
sampl
repres
absorb
chang
incub
control
dmso
sampl
respect
acarbos
use
refer
inhibitor
aglucosidas
oneway
analysi
varianc
anova
pairwis
comparison
tukey
hsd
perform
p
level
use
sigmastat
window
version
jandel
corp
san
rafael
ca
usa
determin
signific
differ
radic
scaveng
capac
egcg
deriv
compound
effect
scaveng
dpph
radic
zhong
shahidi
radic
scaveng
capac
egcg
significantli
enhanc
esterif
process
incorpor
fatti
acid
attribut
increas
lipophil
henc
greater
accessibilityaffin
deriv
lipophil
dpph
radic
parent
egcg
molecul
work
egcg
deriv
evalu
abil
scaveng
biolog
relev
peroxyl
radic
measur
oxygen
radic
absorb
capac
orac
orac
assay
utilis
biolog
relev
radic
sourc
establish
standard
method
assess
activ
hydrophil
antioxid
studi
modifi
orac
assay
procedur
lipophil
antioxid
propos
huang
et
al
employ
procedur
use
acetonewat
solvent
rmcd
solubl
enhanc
result
show
peroxyl
radic
gener
aaph
scaveng
egcg
deriv
compound
greater
extent
fold
refer
antioxid
trolox
fig
compound
examin
antioxid
activ
hydroxyl
group
egcg
esterifi
butyr
acid
leav
hydrogen
donor
avail
orac
valu
deriv
higher
parent
egcg
molecul
indic
greater
hydrogen
atom
donat
abil
test
condit
decreas
number
hydroxyl
group
egcg
deriv
appear
neg
affect
antioxid
activ
test
compound
wright
johnson
dilabio
state
number
hydroxyl
group
egcg
larg
irrelev
antioxid
activ
strateg
place
group
matter
substitu
phenyl
ring
play
essenti
role
efficaci
phenol
antioxid
via
electron
steric
effect
electron
donat
group
ortho
para
posit
abl
lower
activ
energi
hydrogen
abstract
thu
enhanc
hydrogen
donat
abil
antioxid
singh
omalley
popeli
egcg
deriv
oacyl
replac
strong
electron
donat
hydroxyl
group
combin
induct
reson
effect
weaker
electron
donat
ester
group
would
presum
lead
compromis
hydrogen
donat
abil
molecul
howev
substitut
also
hinder
format
moder
strong
hydrogen
bond
adjac
hydroxyl
group
egcg
molecul
intramolecular
hydrogen
bond
contribut
stabilis
molecul
increas
bond
dissoci
enthalpi
bde
oh
bond
ie
resist
hydrogen
atom
dissoci
wright
et
al
orthosubstitut
egcg
might
result
enhanc
hydrogen
atom
donat
capac
reduc
intramolecular
hydrogen
bond
bde
steric
acyl
might
alter
threedimension
conform
egcg
might
facilit
hydrogen
atom
donat
henc
increas
radic
scaveng
capac
conform
characterist
also
import
factor
affect
activ
antioxid
hakamata
et
al
report
planar
catechin
catechol
chroman
structur
constrain
planar
show
hydrogen
transfer
rate
faster
nativ
catechin
scaveng
activ
catechin
dpph
aaph
radic
increas
switch
planar
conform
studi
acyl
hydroxyl
group
phenyl
ring
might
led
planar
conform
format
steric
chang
enhanc
pconjug
substitu
phenyl
ring
henc
hydrogen
donat
abil
molecul
addit
conform
attribut
steric
crowd
caus
incorpor
highmolecularweight
bulki
moieti
might
contribut
greater
hydrogen
donat
abil
egcg
deriv
lucarini
pedrielli
pedulli
demonstr
orthosubstitut
phenol
lower
bde
due
steric
repuls
substitu
hydroxyl
group
especi
substitu
bulki
summari
combin
electron
steric
factor
discuss
might
explain
overal
improv
radic
scaveng
activ
egcg
deriv
among
deriv
compound
contain
pufa
show
higher
orac
valu
compound
satur
alkyl
chain
superior
hydrogen
atom
donat
capac
compound
may
due
presenc
electronrich
doubl
bond
pufa
may
alter
electron
distribut
phenyl
ring
well
bent
structur
pufa
chain
may
help
form
stericallyfavour
conform
facilit
hydrogen
atom
donat
reduc
power
addit
hydrogen
atom
donat
antioxid
may
also
inhibit
oxid
singl
electron
transfer
antioxid
deactiv
free
radic
reduc
oxid
donat
electron
form
antioxid
radic
cation
follow
rapid
revers
deproton
wright
et
al
antioxid
radic
form
stabilis
electron
delocalis
reson
hydrogen
atom
donat
mechan
although
net
result
electron
transfer
hydrogen
atom
transfer
rout
abil
antioxid
donat
electron
hydrogen
atom
may
vari
depend
intrins
extrins
factor
abil
antioxid
act
electron
donor
reduc
power
determin
ionis
potenti
ip
compound
strongli
solventdepend
wright
et
al
reduc
power
egcg
deriv
measur
fe
fe
transform
mediat
test
compound
express
ascorb
acid
known
reduc
agent
equival
result
show
egcg
deriv
compound
exhibit
fold
greater
reduc
power
ascorb
acid
fig
egcg
highest
reduc
power
among
acyl
long
chain
fatti
acid
led
dramat
decreas
reduc
power
found
compound
agreement
free
radic
scaveng
capac
test
compound
fig
poor
correl
observ
may
aris
differ
mechan
well
reaction
environ
involv
two
assay
alreadi
mention
electron
donat
abil
antioxid
depend
ip
may
alter
structur
modif
substitu
phenyl
ring
may
chang
bde
also
ip
presenc
electrondon
substitu
group
stabilis
phenoxyl
radic
cation
henc
lower
ip
enhanc
electron
donat
capabl
therefor
replac
strong
electrondon
hydroxyl
group
weaker
ester
group
result
increas
ip
decreas
reduc
power
antioxid
observ
case
acyl
egcg
show
lower
reduc
power
origin
molecul
opposit
trend
observ
orac
although
phenyl
substitut
influenc
oh
bde
similar
manner
possibl
electron
effect
substitu
hydrogen
atom
donat
counteract
factor
hydrogen
bond
steric
chang
moreov
bde
phenol
antioxid
seem
less
sensit
substitut
ip
exampl
bde
decreas
kcalmol
ip
decreas
kcalmol
aminophenol
methyl
wright
et
al
solubl
also
affect
effect
antioxid
especi
reduc
power
sinc
electron
transfer
mechan
strongli
solvent
depend
due
solvent
stabilis
charg
speci
wright
et
al
egcg
deriv
enhanc
lipophil
zhong
shahidi
poor
solubl
aqueou
media
henc
compromis
activ
hydrophil
test
environ
moreov
might
form
micel
assay
solut
b
ring
bear
long
chain
fatti
acid
moieti
may
buri
hydrophob
core
micel
leav
ring
site
avail
antioxid
action
similar
chang
reduc
power
caus
acyl
found
rutin
ester
lue
et
al
metal
play
import
role
health
exampl
iron
essenti
oxygen
transport
respir
activ
mani
enzym
howev
transit
metal
extrem
reactiv
act
catalyst
lipid
oxid
gener
free
radic
react
hydrogen
lipid
peroxid
produc
hydroxyl
peroxyl
radic
fenton
reaction
iron
copperinduc
ldl
cholesterol
oxid
implic
atherosclerosi
cardiovascular
diseas
metal
chelat
mani
polyphenol
bind
metal
ion
form
stabl
complex
reduc
redox
potenti
thu
suppress
prooxid
effect
metal
ion
egcg
known
metal
chelat
due
vicin
trihydroxi
structur
oxygen
atom
act
electron
donor
form
bond
electrophil
metal
ion
studi
chelat
capac
egcg
ester
deriv
ferrou
ion
evalu
test
compound
exhibit
ferrou
ion
chelat
activ
rang
fig
highest
chelat
activ
found
compound
follow
compound
indic
pufa
ester
egcg
potent
metal
chelat
parent
egcg
satur
ester
compound
show
signific
differ
p
egcg
metal
chelat
abil
relat
geometr
featur
chelatormet
complex
eg
ionic
diamet
ring
size
conform
etc
hassan
therefor
posit
neg
influenc
structur
modif
may
lead
geometr
alter
complex
greater
metal
chelat
capabl
found
egcgpufa
ester
possibl
due
steric
chang
result
bent
structur
pufa
chain
favour
stabil
antioxidantf
complex
electronrich
doubl
bond
pufa
may
also
contribut
stabilis
metal
ion
complex
hepat
c
viru
hcv
infect
seriou
health
threat
global
million
peopl
worldwid
chronic
infect
hcv
qiu
et
al
chronic
infect
hcv
associ
liver
cirrhosi
often
lead
hepat
failur
hepatocellular
carcinoma
hcc
chen
tan
current
approv
therapi
use
interferon
pegyl
interferon
combin
ribavirin
achiev
limit
virolog
respons
rate
signific
patient
popul
eg
infect
hcv
genotyp
shown
side
effect
chen
tan
necessit
develop
new
antivir
drug
proteas
one
thoroughli
characteris
hcv
enzym
becom
import
target
antihcv
treatment
viral
proteas
mediat
cleavag
hcv
polyprotein
releas
function
protein
essenti
viral
propag
inhibitor
proteas
bind
enzym
inhibit
activ
viral
protein
thu
block
hcv
replic
infect
host
cell
chen
njorog
inhibitori
effect
egcg
deriv
hcv
proteas
examin
use
vitro
assay
compar
embelin
known
hcv
proteas
inhibitor
egcg
show
signific
effect
inhibit
proteas
high
ic
valu
lm
compar
posit
control
embelin
lm
shown
tabl
howev
distinct
inhibit
observ
ester
deriv
compound
contain
pufa
display
proteas
inhibitori
activ
stronger
embelin
although
less
effect
compound
compound
inhibit
proteas
approxim
higher
embelin
perbutyr
egcg
compound
hydroxyl
group
occupi
short
chain
acyl
moieti
expect
possess
antioxid
activ
due
absenc
function
oh
group
howev
exhibit
proteas
inhibitori
activ
stronger
embelin
remark
improv
egcg
deriv
inhibit
hcv
proteas
might
aris
chang
steric
featur
hydrophiliclipophil
balanc
hlb
molecul
lead
superior
bind
affin
enzym
studi
antivir
activ
theaflavin
molecular
model
reveal
steric
conform
effect
govern
infect
viru
clark
et
al
studi
ester
deriv
egcg
fatti
acid
especi
long
chain
pufa
bent
chain
structur
may
steric
favour
egcg
bind
proteas
thu
inhibit
function
viru
replic
aglucosidas
inhibitori
activ
aglucosidas
import
hydrolyt
enzym
carbohydr
digest
vital
biosynthesi
viral
envelop
glycoprotein
glycosyl
viral
envelop
glycoprotein
essenti
infect
hiv
inhibit
aglucosidas
provid
promis
strategi
develop
novel
antihiv
drug
moreov
inhibit
aglucosidas
may
also
therapeut
effect
type
ii
diabet
interf
digest
carbohydr
delay
glucos
absorpt
catechin
planar
analogu
investig
aglucosidas
inhibitori
activ
hakamata
et
al
weak
inhibitori
effect
ic
lm
found
catechin
lipophil
planar
analogu
alkyl
chain
incorpor
heterocycl
ring
exhibit
strong
inhibit
ic
lm
aglucosidas
anoth
studi
chlorogen
acid
deriv
suggest
hydrophob
interact
involv
aglucosidas
bind
inhibit
activ
compound
et
al
studi
ester
deriv
egcg
test
aglucosidas
inhibitori
activ
compar
parent
egcg
molecul
posit
control
acarbos
known
aglucosidas
inhibitor
use
reduc
postprandi
hyperglycaemia
tabl
present
ic
valu
test
compound
among
acarbos
found
potent
inhibitor
aglucosidas
egcg
show
highest
ic
valu
lm
among
test
compound
deriv
enhanc
lipophil
significantli
improv
effect
inhibit
aglucosidas
compound
lowest
ic
valu
ie
highest
potenc
aglucosidas
inhibitor
among
deriv
follow
compound
less
lipophil
deriv
compound
less
effect
result
suggest
bind
affin
egcg
rsd
rel
standard
deviat
compound
egcg
tetraest
sa
epa
dha
respect
compound
egcgoctabutyr
deriv
aglucosidas
may
depend
combin
factor
hydrophob
interact
steric
featur
sinc
compound
show
higher
inhibitori
activ
compound
less
hydrophob
ester
deriv
egcg
enhanc
lipophil
exhibit
higher
antioxid
activ
parent
egcg
molecul
scaveng
peroxyl
radic
chelat
prooxid
metal
ion
possibl
due
combin
electron
steric
effect
howev
reduc
power
deriv
lower
egcg
may
explain
poor
solubl
aqueou
test
medium
format
micel
deriv
also
show
excel
antivir
activ
inhibit
hcv
proteas
aglucosidas
signific
egcg
steric
featur
lipophil
deriv
may
respons
increas
bind
affin
enzym
lead
greater
inhibit
result
suggest
lipophil
egcg
deriv
may
use
potenti
function
ingredi
food
cosmet
drug
natur
health
product
health
promot
purpos
howev
find
base
vitro
chemic
assay
research
bioactiv
real
food
biolog
system
need
better
understand
utilis
deriv
function
compound
